Integrated Approach in Frail Older People with Atrial Fibrillation

NCT06775028 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1250

Last updated 2025-01-14

No results posted yet for this study

Summary

The study will verify if a structured multidisciplinary approach (called iABC), aimed to improve the appropriate management of elderly AF patients with multimorbidity (the i-ABC group), would provide a clear evidence of an improvement in clinical conditions and quality of life compared to usual clinical care. The i-ABC group in AFFIRMO will follow the ABC pathway, focused on three domains: avoid stroke with anticoagulation (with optimized VKA or label-adherent DOAC use); better symptom management; and optimized management of associated cardiovascular and non cardiovascular comorbidities.

The study will be conducted in Bulgaria, Denmark, Italy, Romania, Serbia and Spain .

Conditions

Interventions

OTHER

iABC platform use

The novel platform (iABC) that will be used in AFFIRMO will consist of an educational program, a healthy or functional diet/physical activity, guideline-adherent drug treatments, periodic (re)assessment.

Sponsors & Collaborators

  • Aalborg University

    collaborator OTHER
  • Faculty of Medicine, University of Belgrade

    collaborator UNKNOWN
  • Universidad de Murcia

    collaborator OTHER
  • Carol Davila University of Medicine and Pharmacy

    collaborator OTHER
  • Plovdiv Medical University

    collaborator OTHER
  • University of Liverpool

    collaborator OTHER
  • Heart Care Foundation

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-04-11
Primary Completion
2026-01-31
Completion
2026-01-31

Countries

  • Bulgaria
  • Denmark
  • Italy
  • Romania
  • Serbia
  • Spain

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06775028 on ClinicalTrials.gov